Drawing for EQUITAS

USPTO serial 86848934

EQUITAS

Reviewed by CopyMark Law Group

Reg. 5007758Status 701Renewal
Filing date
Status date
Registration date
Jul 26, 2016
Examiner
WIENER, MICHAEL
Law office
TMEG LAW OFFICE 108

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 701: Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary.

Need help with EQUITAS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*

Plus Government fees of $2,550

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
035Pharmaceutical and biopharmaceutical business plan development; business consultation services in the field of pharmaceutical and biopharmaceutical regulatory strategy; business consultation in the field of pharmaceutical and biopharmaceutical foreign market entry; business management services in the field of pharmaceutical and biopharmaceutical products and medical devices; business development and commercial administration of the licensing of pharmaceutical and biopharmaceutical products and medical devices; Providing advertising, marketing and promotional services for pharmaceutical and biopharmaceutical products and medical devices; marketing plan development for pharmaceutical and biopharmaceutical products and medical devices; market research and business analyses and advice for pharmaceutical and biopharmaceutical products and medical devicesACTIVEApr 22, 2015
042Consulting services, namely, pharmaceutical and biopharmaceutical product development; pharmaceutical and biopharmaceutical clinical development and product testing; research and development of pharmaceutical and biopharmaceutical products and medical devicesACTIVEApr 22, 2015
045Consulting in the field of pharmaceutical and biopharmaceutical regulations with regard to regulatory strategyACTIVEApr 22, 2015

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 26, 2025REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Aug 25, 2022NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Aug 25, 20228.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
Aug 2, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 9, 2022ES8RTEAS SECTION 8 RECEIVED—
Jul 26, 2021REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 24, 2020ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Aug 15, 2018ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jul 26, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 10, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 10, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 20, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 29, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 29, 2016DOCKASSIGNED TO EXAMINER—
Dec 19, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 17, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance